120 related articles for article (PubMed ID: 34276260)
1. The Impact of COVID-19 on Drug Use and Harm Reduction Programming in the Middle East and North Africa (MENA) Region: a Regional Consultation of Stakeholders and People Who Use Drugs.
Van Hout MC; Haddad P; Aaraj E
Int J Ment Health Addict; 2022; 20(4):2072-2085. PubMed ID: 34276260
[TBL] [Abstract][Full Text] [Related]
2. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction via online platforms for people who use drugs in Russia: A qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Res Sq; 2020 Sep; ():. PubMed ID: 32995761
[TBL] [Abstract][Full Text] [Related]
4. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
5. How understanding and application of drug-related legal instruments affects harm reduction interventions in Cambodia: a qualitative study.
Tuot S; Ngin C; Pal K; Sou S; Sawez G; Morgan P; Srey M; Chan T; Chhoun P; Golichenko O; Choub SC; Yi S
Harm Reduct J; 2017 Jun; 14(1):39. PubMed ID: 28629463
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
7. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
[TBL] [Abstract][Full Text] [Related]
8. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
Aaraj E; Jreij Abou Chrouch M
Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
[TBL] [Abstract][Full Text] [Related]
9. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
10. The state of harm reduction in the Middle East and North Africa: A focus on Iran and Morocco.
Himmich H; Madani N
Int J Drug Policy; 2016 May; 31():184-9. PubMed ID: 27012581
[TBL] [Abstract][Full Text] [Related]
11. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region.
Al Dawish MA; Robert AA
Curr Diabetes Rev; 2021; 17(5):e211020187087. PubMed ID: 33087031
[TBL] [Abstract][Full Text] [Related]
13. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
[TBL] [Abstract][Full Text] [Related]
14. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
[TBL] [Abstract][Full Text] [Related]
15. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 Pandemic on Alcohol Treatment Access and Harm Prevention in West Africa: Reports from NGOs and Community-Based Organizations.
Swahn MH; Balenger A; Umenze F; Aneja R; Bureh TA; W Dumbili E; Obot I
J Epidemiol Glob Health; 2022 Jun; 12(2):160-167. PubMed ID: 35380418
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of HIV infection in the Middle East and North Africa.
Abu-Raddad LJ; Hilmi N; Mumtaz G; Benkirane M; Akala FA; Riedner G; Tawil O; Wilson D
AIDS; 2010 Jul; 24 Suppl 2():S5-23. PubMed ID: 20610949
[TBL] [Abstract][Full Text] [Related]
18. Harm Reduction Services in Ottawa: The Culture of Drug Use.
Haines M; O'Byrne P
Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
[TBL] [Abstract][Full Text] [Related]
19. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
[TBL] [Abstract][Full Text] [Related]
20. Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders Network.
Abusrewil S; Algeer A; Aljifri A; Al Slail F; Andrew MK; Awad Tag Eldin M; Al Awaidy S; Ben Alaya N; Ben Khelil J; Dbaibo G; Derrar F; Elahmer O; Ghosn N; Gabriel G; Grasso C; Hassan M; Hirve S; Mirza YK; Rateb YM; Nourlil J; Nunes MC; Omaima I; Malande OO; Saadatian-Elahi M; Sanchez-Picot V; Sk Mamunur Rahman M; Tarraf H; Walaza S
Influenza Other Respir Viruses; 2019 May; 13(3):298-304. PubMed ID: 30801995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
